```html

Atopic Dermatitis (Eczema)

What is Atopic Dermatitis (Eczema)?

Atopic dermatitis (AD), commonly called eczema, is a chronic, inflammatory skin disease that causes dry, itchy, and red patches. It is one of the most common skin disorders in both children and adults, affecting up to 10 % of the population. The disease often follows a relapsing‑remitting course—periods of flare‑ups alternate with times when the skin improves.

AD belongs to the broader group of atopic diseases, which also includes asthma and allergic rhinitis. The underlying problem is a combination of genetic susceptibility, skin‑barrier dysfunction, and an over‑active immune response.

Common Causes

While no single factor “causes” atopic dermatitis, several triggers can initiate or worsen a flare. Most people have more than one contributing factor.

• Genetic predisposition: Mutations in the FLG (filaggrin) gene weaken the skin’s barrier.
• Environmental allergens: Dust mites, pollen, pet dander, and mold.
• Contact irritants: Soaps, detergents, fragrances, and certain fabrics (especially wool or synthetic blends).
• Climate factors: Low humidity, cold weather, or excessive heat and sweating.
• Microbial colonisation: Staphylococcus aureus overgrowth on the skin.
• Food allergies: Cow’s milk, egg, soy, wheat, and peanuts (more common in infants).
• Stress and emotional factors: Anxiety and depression can exacerbate itching.
• Hormonal changes: Puberty, menstrual cycles, or pregnancy may worsen symptoms.
• Skin trauma (Koebner phenomenon): Scratches, cuts, or even tight clothing can provoke new lesions.
• Medications: Certain antibiotics, lithium, or interferon can trigger flare‑ups.

Associated Symptoms

AD does not occur in isolation; patients often experience additional signs and related conditions.

• Intense itching (pruritus) – the most distressing symptom.
• Dry, scaly skin that may crack or bleed.
• Thickened, leathery plaques (lichenification) from chronic scratching.
• Red or brownish‑gray patches, especially on the face, neck, bends of elbows/knees, and hands.
• Secondary bacterial or fungal infections (e.g., impetigo, Candida).
• Sleep disturbance due to night‑time itching.
• Psychological impact: anxiety, depression, and reduced quality of life.
• Association with other atopic diseases: asthma, allergic rhinitis, and food allergies.

When to See a Doctor

Most mild cases can be managed at home, but you should contact a healthcare professional when any of the following occur:

• Skin becomes increasingly red, swollen, or warm – signs of infection.
• Fever ≥ 38 °C (100.4 °F) accompanies a flare.
• Rapid spreading of rash or appearance of new lesions despite regular treatment.
• Severe, unrelenting itch that interferes with sleep or daily activities.
• Visible oozing, crusting, or pus formation.
• Signs of an allergic reaction to a new product (hives, swelling of lips/tongue).
• Concern about cosmetic impact or psychosocial distress.

Diagnosis

Diagnosis of atopic dermatitis is primarily clinical, based on a detailed history and physical examination.

1. Clinical History

• Age of onset (most common before age 2).
• Distribution of rash (flexural areas in children; hands, face, and neck in adults).
• Family history of atopy (eczema, asthma, hay fever).
• Trigger identification (food, environment, stress).

2. Physical Examination

• Typical morphology: erythema, edema, vesicles, crusts, or lichenified plaques.
• Assessment of skin barrier: dryness, fissures, and scale.
• Check for secondary infection (yellow crusts, pustules).

3. Diagnostic Tools (when needed)

• Skin prick or specific IgE testing: Identifies allergic sensitisation.
• Patch testing: Useful when contact dermatitis is suspected.
• Skin swab or culture: If bacterial infection is suspected.
• Blood eosinophil count or total IgE: May be elevated but not diagnostic.

Treatment Options

Therapy aims to reduce inflammation, repair the skin barrier, relieve itching, and prevent flares. Management is usually stepped‑up based on severity.

1. Skincare & Lifestyle Measures

• Moisturize liberally: Use fragrance‑free emollients (e.g., petrolatum, ceramide‑containing creams) at least twice daily.
• Gentle cleansing: Avoid harsh soaps; opt for pH‑balanced, fragrance‑free cleansers.
• Bathing technique: Warm (not hot) water for 10‑15 min, add oatmeal or colloidal zinc sulfate, then pat dry and apply moisturizer while skin is still damp.
• Identify and avoid triggers: Keep a symptom diary.
• Clothing: Soft, breathable fabrics (cotton); avoid wool and synthetics that cause friction.

2. Pharmacologic Therapy

Topical Medications

• Low‑ to moderate‑strength corticosteroids: First‑line for acute flares (e.g., hydrocortisone 1 %, triamcinolone 0.1 %). Use sparingly and for the shortest duration possible.
• High‑potency steroids: Clobetasol propionate 0.05 % for severe areas (thick plaques) – usually for ≤2 weeks.
• Topical calcineurin inhibitors (TCIs): Tacrolimus 0.03 % or pimecrolimus 1 % – useful on face/neck and for steroid‑sparing.
• Crisaborole 2 % ointment: A phosphodiesterase‑4 inhibitor for mild‑to‑moderate disease.
• Barrier repair creams: Ceramide‑rich products (e.g., CeraVe, EpiCeram) help restore lipid layers.

Systemic Therapies

• Oral antihistamines: Helpful mainly for night‑time itch; non‑sedating (cetirizine) or sedating (diphenhydramine) as needed.
• Oral corticosteroids: Short bursts for severe flares only; not recommended long‑term due to side effects.
• Immunosuppressants: Cyclosporine, methotrexate, or azathioprine for refractory disease under specialist care.
• Biologic agents: Dupilumab (IL‑4Rα antagonist) is FDA‑approved for moderate‑to‑severe AD in adults and children ≥6 years; newer agents (e.g., tralokinumab, lebrikizumab) are emerging.
• JAK inhibitors: Oral (upadacitinib, baricitinib) and topical (ruxolitinib) have shown efficacy for moderate‑to‑severe disease.

Adjunctive Treatments

• Wet‑wrap therapy for acute, extensive flares.
• Phototherapy (narrow‑band UVB) under dermatology supervision.
• Antibiotics (topical mupirocin or oral clindamycin) when bacterial infection is confirmed.
• Antifungals (e.g., ketoconazole) for associated candida infection.

3. Psychological Support

Because chronic itch and visible lesions can affect mental health, referral to counseling, cognitive‑behavioral therapy, or support groups is often beneficial.

Prevention Tips

While genetics cannot be changed, many practical steps can reduce the frequency and severity of flares.

• Maintain skin hydration: Apply emollient within 3 minutes of bathing.
• Use mild cleansers and avoid hot water.
• Identify personal triggers: Keep a log of foods, soaps, weather, and stress levels.
• Wear cotton layers and keep nails short to minimise scratching damage.
• Control indoor humidity (30‑50 %) during winter.
• Regularly wash bedding in hot water to reduce dust‑mite exposure.
• Consider probiotic supplementation (evidence is modest but some studies suggest benefit in children).
• Stay up‑to‑date on vaccinations – infections can precipitate eczema flares.

Emergency Warning Signs

Key Take‑aways

Atopic dermatitis is a common, chronic skin condition driven by genetic, immunologic, and environmental factors. Early, consistent skin‑care routines and appropriate use of topical medications often keep the disease under control. Recognizing infection signs, severe itching, or systemic symptoms is essential for timely medical intervention. When flares become frequent or debilitating, a dermatologist can tailor systemic or biologic therapies. By understanding triggers, maintaining barrier health, and seeking care when red flags appear, most individuals can achieve long‑term symptom relief and an improved quality of life.

---

Sources: Mayo Clinic, CDC, National Institute of Allergy and Infectious Diseases (NIAID), American Academy of Dermatology, WHO, Cleveland Clinic, JAMA Dermatology, and peer‑reviewed clinical guidelines (2023‑2024).

```